Stock Movers Palantir Drops, Uber Earnings, Pfizer Boosts Forecast
Nov 4, 2025
Palantir's shares drop despite a strong earnings beat, raising concerns about its high valuation. Uber reports robust quarterly growth as customers increasingly utilize their diverse services, yet the stock reacts negatively. Meanwhile, Pfizer boosts its 2025 profit forecast, thanks to cost cuts amidst its acquisitions, including the obesity startup Metsera. Additionally, iHeartMedia's stock surges on talks to license Netflix podcasts, while Denny's sees a significant share spike after a large take-private deal.
AI Snips
Chapters
Transcript
Episode notes
Strong Results Can't Cure Rich Valuation
- Palantir beat expectations but shares fell as investors worried about its rich valuation after a huge year-to-date rally.
- Kriti Gupta highlights that strong results don't always prevent a sell-off when sentiment targets stretched stocks.
Tech Sentiment Can Override Earnings Beats
- Uber posted stronger-than-expected third-quarter gross bookings and showed growth across rides and deliveries.
- Nathan Hager and Kriti Gupta note the stock fell despite the beat, suggesting tech sentiment is pressuring even good earnings.
Cost Cuts Support Pharma Forecasts
- Pfizer raised its 2025 profit forecast after cost cuts offset slow sales growth in some areas.
- Kriti Gupta points out Pfizer's diversification push, including competition for MetSera in obesity treatments.